View Future GrowthNabaltec 과거 순이익 실적과거 기준 점검 2/6Nabaltec은 연평균 14.7%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 4.4% 감소했습니다. 매출은 연평균 2%의 비율로 증가했습니다. Nabaltec의 자기자본이익률은 5.4%이고 순이익률은 4.4%입니다.핵심 정보14.65%순이익 성장률14.31%주당순이익(EPS) 성장률Chemicals 산업 성장률12.41%매출 성장률2.01%자기자본이익률5.42%순이익률4.43%다음 순이익 업데이트20 Aug 2026최근 과거 실적 업데이트Reported Earnings • May 22First quarter 2026 earnings released: EPS: €0.20 (vs €0.31 in 1Q 2025)First quarter 2026 results: EPS: €0.20 (down from €0.31 in 1Q 2025). Revenue: €54.1m (down 1.8% from 1Q 2025). Net income: €1.80m (down 35% from 1Q 2025). Profit margin: 3.3% (down from 5.0% in 1Q 2025). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year whereas the company’s share price has fallen by 19% per year.공시 • Dec 11+ 3 more updatesNabaltec AG to Report Fiscal Year 2025 Results on Apr 30, 2026Nabaltec AG announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 30, 2026공시 • Feb 16+ 3 more updatesNabaltec AG to Report Q3, 2025 Results on Nov 20, 2025Nabaltec AG announced that they will report Q3, 2025 results on Nov 20, 2025Reported Earnings • Aug 25Second quarter 2024 earnings released: EPS: €0.46 (vs €0.27 in 2Q 2023)Second quarter 2024 results: EPS: €0.46 (up from €0.27 in 2Q 2023). Revenue: €55.2m (up 12% from 2Q 2023). Net income: €4.07m (up 69% from 2Q 2023). Profit margin: 7.4% (up from 4.9% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.Reported Earnings • May 26First quarter 2024 earnings released: EPS: €0.39 (vs €0.35 in 1Q 2023)First quarter 2024 results: EPS: €0.39 (up from €0.35 in 1Q 2023). Revenue: €55.0m (down 3.8% from 1Q 2023). Net income: €3.40m (up 9.7% from 1Q 2023). Profit margin: 6.2% (up from 5.4% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 26Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: €1.30 (down from €3.00 in FY 2022). Revenue: €203.3m (down 7.4% from FY 2022). Net income: €11.4m (down 57% from FY 2022). Profit margin: 5.6% (down from 12% in FY 2022). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 14%. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updatesReported Earnings • May 22First quarter 2026 earnings released: EPS: €0.20 (vs €0.31 in 1Q 2025)First quarter 2026 results: EPS: €0.20 (down from €0.31 in 1Q 2025). Revenue: €54.1m (down 1.8% from 1Q 2025). Net income: €1.80m (down 35% from 1Q 2025). Profit margin: 3.3% (down from 5.0% in 1Q 2025). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year whereas the company’s share price has fallen by 19% per year.Declared Dividend • May 20Dividend of €0.29 announcedDividend of €0.29 is the same as last year. Ex-date: 25th June 2026 Payment date: 29th June 2026 Dividend yield will be 2.7%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (26% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 9.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 42% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • May 12+ 1 more updateNabaltec AG announces Annual dividend, payable on June 29, 2026Nabaltec AG announced Annual dividend of EUR 0.2900 per share payable on June 29, 2026, ex-date on June 25, 2026 and record date on June 26, 2026.공시 • Dec 11+ 3 more updatesNabaltec AG to Report Fiscal Year 2025 Results on Apr 30, 2026Nabaltec AG announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 30, 2026공시 • Jun 26Nabaltec AG Resolves to Distribute A DividendNabaltec AG at the AGM held on 25 June 2025, resolved to distribute a dividend totaling EUR 2.55 million, which corresponds to a payout of EUR 0.29 per share (previous year: EUR 0.28 per share). The remaining distributable profit of EUR 60.0 million will be carried forward to new account and thus contribute to strengthening the company’s equity – an important step in further implementing the company’s growth strategy.공시 • May 23Nabaltec Ag Affirms Earnings Guidance for 2025Nabaltec AG affirmed earnings guidance for 2025. For the period, the company expects Revenue growth in a range of 3% to 5%; EBIT margin in a range of 7% to 9%.공시 • May 13Nabaltec AG, Annual General Meeting, Jun 25, 2025Nabaltec AG, Annual General Meeting, Jun 25, 2025, at 10:00 W. Europe Standard Time.공시 • May 07Nabaltec AG announces Annual dividend, payable on June 30, 2025Nabaltec AG announced Annual dividend of EUR 0.2900 per share payable on June 30, 2025, ex-date on June 26, 2025 and record date on June 27, 2025.공시 • Feb 16+ 3 more updatesNabaltec AG to Report Q3, 2025 Results on Nov 20, 2025Nabaltec AG announced that they will report Q3, 2025 results on Nov 20, 2025New Risk • Aug 25New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.0% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.6% net profit margin).Reported Earnings • Aug 25Second quarter 2024 earnings released: EPS: €0.46 (vs €0.27 in 2Q 2023)Second quarter 2024 results: EPS: €0.46 (up from €0.27 in 2Q 2023). Revenue: €55.2m (up 12% from 2Q 2023). Net income: €4.07m (up 69% from 2Q 2023). Profit margin: 7.4% (up from 4.9% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.Upcoming Dividend • Jun 19Upcoming dividend of €0.28 per shareEligible shareholders must have bought the stock before 26 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.2%).Reported Earnings • May 26First quarter 2024 earnings released: EPS: €0.39 (vs €0.35 in 1Q 2023)First quarter 2024 results: EPS: €0.39 (up from €0.35 in 1Q 2023). Revenue: €55.0m (down 3.8% from 1Q 2023). Net income: €3.40m (up 9.7% from 1Q 2023). Profit margin: 6.2% (up from 5.4% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.Declared Dividend • May 13Dividend of €0.28 announcedShareholders will receive a dividend of €0.28. Ex-date: 26th June 2024 Payment date: 28th June 2024 Dividend yield will be 1.9%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (22% earnings payout ratio) but not covered by cash flows (102% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 2 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Apr 26Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: €1.30 (down from €3.00 in FY 2022). Revenue: €203.3m (down 7.4% from FY 2022). Net income: €11.4m (down 57% from FY 2022). Profit margin: 5.6% (down from 12% in FY 2022). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 14%. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Jan 26Now 20% undervaluedOver the last 90 days, the stock has risen 18% to €17.10. The fair value is estimated to be €21.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 79%. Revenue is forecast to grow by 5.4% in 2 years. Earnings are forecast to grow by 32% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €17.90, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 22% over the past three years.Buying Opportunity • Jan 10Now 20% undervaluedOver the last 90 days, the stock is up 14%. The fair value is estimated to be €21.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 79%. Revenue is forecast to grow by 5.4% in 2 years. Earnings is forecast to grow by 32% in the next 2 years.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €18.65, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in Germany. Total loss to shareholders of 30% over the past three years.Buying Opportunity • Nov 25Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be €19.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 79%. Revenue is forecast to grow by 5.4% in 2 years. Earnings is forecast to grow by 32% in the next 2 years.Reported Earnings • Nov 23Third quarter 2023 earnings released: EPS: €0.33 (vs €1.38 in 3Q 2022)Third quarter 2023 results: EPS: €0.33 (down from €1.38 in 3Q 2022). Revenue: €51.1m (down 9.9% from 3Q 2022). Net income: €2.92m (down 76% from 3Q 2022). Profit margin: 5.7% (down from 22% in 3Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.New Risk • Nov 23New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.0% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.0% net profit margin).공시 • Nov 19+ 4 more updatesNabaltec AG to Report First Half, 2024 Results on Aug 22, 2024Nabaltec AG announced that they will report first half, 2024 results on Aug 22, 2024New Risk • Oct 16New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 2.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.4% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buying Opportunity • Sep 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be €21.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 82%. Revenue is forecast to grow by 7.8% in 2 years. Earnings is forecast to decline by 13% in the next 2 years.Reported Earnings • Aug 27Second quarter 2023 earnings released: EPS: €0.27 (vs €0.64 in 2Q 2022)Second quarter 2023 results: EPS: €0.27 (down from €0.64 in 2Q 2022). Revenue: €49.2m (down 12% from 2Q 2022). Net income: €2.41m (down 57% from 2Q 2022). Profit margin: 4.9% (down from 10.0% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.New Risk • Aug 18New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.2% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.공시 • Jun 29Nabaltec AG Approves DividendNabaltec AG announced that at its AGM held on June 28, 2023, the shareholders approved distribute a dividend totaling EUR 2.46 million. This corresponds to EUR 0.28 per share. The remaining distributable profit of EUR 41.1 million will be carried forward to new account and thus left in the company to further strengthen liquidity.Upcoming Dividend • Jun 22Upcoming dividend of €0.28 per share at 1.4% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 9.9% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (6.3%).공시 • May 26Nabaltec AG Provides Earnings Guidance for the Full Year 2023Nabaltec AG provided earnings guidance for the full year 2023. For the period, the company expects revenue growth of 3% to 5% and EBIT margin of 8% to 10%.Reported Earnings • May 03Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €3.00 (up from €1.85 in FY 2021). Revenue: €222.8m (up 19% from FY 2021). Net income: €26.4m (up 62% from FY 2021). Profit margin: 12% (up from 8.7% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.1%. Revenue is expected to decline by 2.5% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Price Target Changed • Mar 28Price target decreased by 10% to €31.00Down from €34.50, the current price target is provided by 1 analyst. New target price is 35% above last closing price of €22.90. Stock is down 28% over the past year. The company is forecast to post earnings per share of €2.75 for next year compared to €1.85 last year.Price Target Changed • Nov 29Price target increased to €34.50Up from €31.50, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €23.80. Stock is down 33% over the past year. The company is forecast to post earnings per share of €2.75 for next year compared to €1.85 last year.Reported Earnings • Nov 27Third quarter 2022 earnings released: EPS: €1.38 (vs €0.49 in 3Q 2021)Third quarter 2022 results: EPS: €1.38 (up from €0.49 in 3Q 2021). Revenue: €56.6m (up 21% from 3Q 2021). Net income: €12.1m (up 183% from 3Q 2021). Profit margin: 22% (up from 9.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Price Target Changed • Nov 16Price target decreased to €31.50Down from €36.00, the current price target is an average from 2 analysts. New target price is 53% above last closing price of €20.60. Stock is down 44% over the past year. The company is forecast to post earnings per share of €1.85 for next year compared to €1.85 last year.공시 • Nov 08+ 4 more updatesNabaltec AG, Annual General Meeting, Jun 28, 2023Nabaltec AG, Annual General Meeting, Jun 28, 2023.Price Target Changed • Oct 20Price target decreased to €31.50Down from €36.00, the current price target is an average from 2 analysts. New target price is 54% above last closing price of €20.50. Stock is down 36% over the past year. The company is forecast to post earnings per share of €2.03 for next year compared to €1.85 last year.Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: €0.64 (vs €0.49 in 2Q 2021)Second quarter 2022 results: EPS: €0.64 (up from €0.49 in 2Q 2021). Revenue: €57.3m (up 19% from 2Q 2021). Net income: €5.60m (up 29% from 2Q 2021). Profit margin: 9.8% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 9.0%, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 6% per year.Valuation Update With 7 Day Price Move • Jul 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to €26.90, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 8x in the Chemicals industry in Germany. Total loss to shareholders of 18% over the past three years.Upcoming Dividend • Jun 23Upcoming dividend of €0.25 per shareEligible shareholders must have bought the stock before 30 June 2022. Payment date: 04 July 2022. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.7%).Reported Earnings • Jun 04First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.53 (up from €0.27 in 1Q 2021). Revenue: €55.0m (up 19% from 1Q 2021). Net income: €4.67m (up 96% from 1Q 2021). Profit margin: 8.5% (up from 5.2% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 14%, compared to a 6.2% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Price Target Changed • May 24Price target decreased to €37.50Down from €41.00, the current price target is an average from 2 analysts. New target price is 37% above last closing price of €27.40. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.92 for next year compared to €1.85 last year.Reported Earnings • Apr 30Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: €1.85 loss per share (up from €2.23 loss in FY 2020). Revenue: €190.2m (up 19% from FY 2020). Net income: €16.3m (up €35.9m from FY 2020). Profit margin: 8.5% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 13%, compared to a 11% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 27Third quarter 2021 earnings: EPS exceeds analyst expectationsThird quarter 2021 results: EPS: €0.49 (up from €0.15 in 3Q 2020). Revenue: €47.4m (up 28% from 3Q 2020). Net income: €4.30m (up 217% from 3Q 2020). Profit margin: 9.1% (up from 3.6% in 3Q 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) exceeded analyst estimates. Earnings per share (EPS) surpassed analyst estimates. Over the next year, revenue is forecast to grow 11%, compared to a 4.4% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 113 percentage points per year, which is a significant difference in performance.Price Target Changed • Oct 29Price target increased to €40.50Up from €37.00, the current price target is an average from 3 analysts. New target price is 23% above last closing price of €33.00. Stock is up 66% over the past year. The company is forecast to post earnings per share of €1.50 next year compared to a net loss per share of €2.23 last year.Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS €0.49 (vs €0.12 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €48.5m (up 33% from 2Q 2020). Net income: €4.35m (up €5.40m from 2Q 2020). Profit margin: 9.0% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 100 percentage points per year, which is a significant difference in performance.Reported Earnings • May 28First quarter 2021 earnings released: EPS €0.27 (vs €0.14 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €46.1m (up 1.3% from 1Q 2020). Net income: €2.38m (up 98% from 1Q 2020). Profit margin: 5.2% (up from 2.6% in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance.Price Target Changed • May 15Price target increased to €37.00Up from €31.50, the current price target is an average from 2 analysts. New target price is 15% above last closing price of €32.20. Stock is up 56% over the past year.Reported Earnings • May 02Full year 2020 earnings released: €2.23 loss per share (vs €1.22 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: €162.5m (down 9.6% from FY 2019). Net loss: €19.7m (down 284% from profit in FY 2019). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.Price Target Changed • Apr 30Price target increased to €33.50Up from €30.50, the current price target is an average from 2 analysts. New target price is 6.0% above last closing price of €31.60. Stock is up 41% over the past year.Is New 90 Day High Low • Feb 27New 90-day high: €29.80The company is up 15% from its price of €25.90 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €28.95 per share.Is New 90 Day High Low • Nov 11New 90-day high: €23.00The company is up 21% from its price of €19.00 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €62.62 per share.Is New 90 Day High Low • Oct 11New 90-day high: €21.00The company is up 2.0% from its price of €20.60 on 13 July 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €60.09 per share.매출 및 비용 세부 내역Nabaltec가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:NTG 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Mar 26197943031 Dec 251991043030 Sep 252021243030 Jun 252031342031 Mar 252061442031 Dec 242051442030 Sep 242041441030 Jun 242041340031 Mar 241981240031 Dec 232011139030 Sep 232081241030 Jun 232152241031 Mar 232222541031 Dec 222202641030 Sep 222142839030 Jun 222052038031 Mar 221971937031 Dec 211881636030 Sep 21182-1035030 Jun 21172-1333031 Mar 21161-1832031 Dec 20160-2033030 Sep 20157234030 Jun 20164336031 Mar 20177837031 Dec 191801137030 Sep 191841337030 Jun 191831336031 Mar 191811135031 Dec 181771034030 Sep 181741034030 Jun 181721033031 Mar 181711233031 Dec 171691132030 Sep 17168934030 Jun 17165734031 Mar 17163633031 Dec 16160533030 Sep 16159729030 Jun 16158728031 Mar 16155628031 Dec 15152728030 Sep 15150628030 Jun 151497270양질의 수익: NTG는 고품질 수익을 보유하고 있습니다.이익 마진 증가: NTG의 현재 순 이익률 (4.4%)은 지난해 (6.6%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: NTG는 지난 5년 동안 흑자전환하며 연평균 14.7%의 수익 성장을 기록했습니다.성장 가속화: NTG은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: NTG은 지난 1년 동안 수익이 감소(-36%)하여 Chemicals 업계 평균(-13.5%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: NTG의 자본 수익률(5.4%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 08:55종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nabaltec AG는 4명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Volker BosseBaader Helvea Equity ResearchAndrew KeenEdison Investment ResearchChristian SandherrHauck Aufhäuser Investment Banking1명의 분석가 더 보기
Reported Earnings • May 22First quarter 2026 earnings released: EPS: €0.20 (vs €0.31 in 1Q 2025)First quarter 2026 results: EPS: €0.20 (down from €0.31 in 1Q 2025). Revenue: €54.1m (down 1.8% from 1Q 2025). Net income: €1.80m (down 35% from 1Q 2025). Profit margin: 3.3% (down from 5.0% in 1Q 2025). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year whereas the company’s share price has fallen by 19% per year.
공시 • Dec 11+ 3 more updatesNabaltec AG to Report Fiscal Year 2025 Results on Apr 30, 2026Nabaltec AG announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 30, 2026
공시 • Feb 16+ 3 more updatesNabaltec AG to Report Q3, 2025 Results on Nov 20, 2025Nabaltec AG announced that they will report Q3, 2025 results on Nov 20, 2025
Reported Earnings • Aug 25Second quarter 2024 earnings released: EPS: €0.46 (vs €0.27 in 2Q 2023)Second quarter 2024 results: EPS: €0.46 (up from €0.27 in 2Q 2023). Revenue: €55.2m (up 12% from 2Q 2023). Net income: €4.07m (up 69% from 2Q 2023). Profit margin: 7.4% (up from 4.9% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
Reported Earnings • May 26First quarter 2024 earnings released: EPS: €0.39 (vs €0.35 in 1Q 2023)First quarter 2024 results: EPS: €0.39 (up from €0.35 in 1Q 2023). Revenue: €55.0m (down 3.8% from 1Q 2023). Net income: €3.40m (up 9.7% from 1Q 2023). Profit margin: 6.2% (up from 5.4% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 26Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: €1.30 (down from €3.00 in FY 2022). Revenue: €203.3m (down 7.4% from FY 2022). Net income: €11.4m (down 57% from FY 2022). Profit margin: 5.6% (down from 12% in FY 2022). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 14%. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
Reported Earnings • May 22First quarter 2026 earnings released: EPS: €0.20 (vs €0.31 in 1Q 2025)First quarter 2026 results: EPS: €0.20 (down from €0.31 in 1Q 2025). Revenue: €54.1m (down 1.8% from 1Q 2025). Net income: €1.80m (down 35% from 1Q 2025). Profit margin: 3.3% (down from 5.0% in 1Q 2025). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year whereas the company’s share price has fallen by 19% per year.
Declared Dividend • May 20Dividend of €0.29 announcedDividend of €0.29 is the same as last year. Ex-date: 25th June 2026 Payment date: 29th June 2026 Dividend yield will be 2.7%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (26% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 9.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 42% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 12+ 1 more updateNabaltec AG announces Annual dividend, payable on June 29, 2026Nabaltec AG announced Annual dividend of EUR 0.2900 per share payable on June 29, 2026, ex-date on June 25, 2026 and record date on June 26, 2026.
공시 • Dec 11+ 3 more updatesNabaltec AG to Report Fiscal Year 2025 Results on Apr 30, 2026Nabaltec AG announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 30, 2026
공시 • Jun 26Nabaltec AG Resolves to Distribute A DividendNabaltec AG at the AGM held on 25 June 2025, resolved to distribute a dividend totaling EUR 2.55 million, which corresponds to a payout of EUR 0.29 per share (previous year: EUR 0.28 per share). The remaining distributable profit of EUR 60.0 million will be carried forward to new account and thus contribute to strengthening the company’s equity – an important step in further implementing the company’s growth strategy.
공시 • May 23Nabaltec Ag Affirms Earnings Guidance for 2025Nabaltec AG affirmed earnings guidance for 2025. For the period, the company expects Revenue growth in a range of 3% to 5%; EBIT margin in a range of 7% to 9%.
공시 • May 13Nabaltec AG, Annual General Meeting, Jun 25, 2025Nabaltec AG, Annual General Meeting, Jun 25, 2025, at 10:00 W. Europe Standard Time.
공시 • May 07Nabaltec AG announces Annual dividend, payable on June 30, 2025Nabaltec AG announced Annual dividend of EUR 0.2900 per share payable on June 30, 2025, ex-date on June 26, 2025 and record date on June 27, 2025.
공시 • Feb 16+ 3 more updatesNabaltec AG to Report Q3, 2025 Results on Nov 20, 2025Nabaltec AG announced that they will report Q3, 2025 results on Nov 20, 2025
New Risk • Aug 25New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.0% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.6% net profit margin).
Reported Earnings • Aug 25Second quarter 2024 earnings released: EPS: €0.46 (vs €0.27 in 2Q 2023)Second quarter 2024 results: EPS: €0.46 (up from €0.27 in 2Q 2023). Revenue: €55.2m (up 12% from 2Q 2023). Net income: €4.07m (up 69% from 2Q 2023). Profit margin: 7.4% (up from 4.9% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Jun 19Upcoming dividend of €0.28 per shareEligible shareholders must have bought the stock before 26 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.2%).
Reported Earnings • May 26First quarter 2024 earnings released: EPS: €0.39 (vs €0.35 in 1Q 2023)First quarter 2024 results: EPS: €0.39 (up from €0.35 in 1Q 2023). Revenue: €55.0m (down 3.8% from 1Q 2023). Net income: €3.40m (up 9.7% from 1Q 2023). Profit margin: 6.2% (up from 5.4% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
Declared Dividend • May 13Dividend of €0.28 announcedShareholders will receive a dividend of €0.28. Ex-date: 26th June 2024 Payment date: 28th June 2024 Dividend yield will be 1.9%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by earnings (22% earnings payout ratio) but not covered by cash flows (102% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Apr 26Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: €1.30 (down from €3.00 in FY 2022). Revenue: €203.3m (down 7.4% from FY 2022). Net income: €11.4m (down 57% from FY 2022). Profit margin: 5.6% (down from 12% in FY 2022). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 14%. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Jan 26Now 20% undervaluedOver the last 90 days, the stock has risen 18% to €17.10. The fair value is estimated to be €21.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 79%. Revenue is forecast to grow by 5.4% in 2 years. Earnings are forecast to grow by 32% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €17.90, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 22% over the past three years.
Buying Opportunity • Jan 10Now 20% undervaluedOver the last 90 days, the stock is up 14%. The fair value is estimated to be €21.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 79%. Revenue is forecast to grow by 5.4% in 2 years. Earnings is forecast to grow by 32% in the next 2 years.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €18.65, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in Germany. Total loss to shareholders of 30% over the past three years.
Buying Opportunity • Nov 25Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be €19.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 79%. Revenue is forecast to grow by 5.4% in 2 years. Earnings is forecast to grow by 32% in the next 2 years.
Reported Earnings • Nov 23Third quarter 2023 earnings released: EPS: €0.33 (vs €1.38 in 3Q 2022)Third quarter 2023 results: EPS: €0.33 (down from €1.38 in 3Q 2022). Revenue: €51.1m (down 9.9% from 3Q 2022). Net income: €2.92m (down 76% from 3Q 2022). Profit margin: 5.7% (down from 22% in 3Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
New Risk • Nov 23New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.0% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.0% net profit margin).
공시 • Nov 19+ 4 more updatesNabaltec AG to Report First Half, 2024 Results on Aug 22, 2024Nabaltec AG announced that they will report first half, 2024 results on Aug 22, 2024
New Risk • Oct 16New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 2.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.4% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buying Opportunity • Sep 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be €21.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 82%. Revenue is forecast to grow by 7.8% in 2 years. Earnings is forecast to decline by 13% in the next 2 years.
Reported Earnings • Aug 27Second quarter 2023 earnings released: EPS: €0.27 (vs €0.64 in 2Q 2022)Second quarter 2023 results: EPS: €0.27 (down from €0.64 in 2Q 2022). Revenue: €49.2m (down 12% from 2Q 2022). Net income: €2.41m (down 57% from 2Q 2022). Profit margin: 4.9% (down from 10.0% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
New Risk • Aug 18New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.2% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
공시 • Jun 29Nabaltec AG Approves DividendNabaltec AG announced that at its AGM held on June 28, 2023, the shareholders approved distribute a dividend totaling EUR 2.46 million. This corresponds to EUR 0.28 per share. The remaining distributable profit of EUR 41.1 million will be carried forward to new account and thus left in the company to further strengthen liquidity.
Upcoming Dividend • Jun 22Upcoming dividend of €0.28 per share at 1.4% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 9.9% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (6.3%).
공시 • May 26Nabaltec AG Provides Earnings Guidance for the Full Year 2023Nabaltec AG provided earnings guidance for the full year 2023. For the period, the company expects revenue growth of 3% to 5% and EBIT margin of 8% to 10%.
Reported Earnings • May 03Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €3.00 (up from €1.85 in FY 2021). Revenue: €222.8m (up 19% from FY 2021). Net income: €26.4m (up 62% from FY 2021). Profit margin: 12% (up from 8.7% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.1%. Revenue is expected to decline by 2.5% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Price Target Changed • Mar 28Price target decreased by 10% to €31.00Down from €34.50, the current price target is provided by 1 analyst. New target price is 35% above last closing price of €22.90. Stock is down 28% over the past year. The company is forecast to post earnings per share of €2.75 for next year compared to €1.85 last year.
Price Target Changed • Nov 29Price target increased to €34.50Up from €31.50, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €23.80. Stock is down 33% over the past year. The company is forecast to post earnings per share of €2.75 for next year compared to €1.85 last year.
Reported Earnings • Nov 27Third quarter 2022 earnings released: EPS: €1.38 (vs €0.49 in 3Q 2021)Third quarter 2022 results: EPS: €1.38 (up from €0.49 in 3Q 2021). Revenue: €56.6m (up 21% from 3Q 2021). Net income: €12.1m (up 183% from 3Q 2021). Profit margin: 22% (up from 9.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Price Target Changed • Nov 16Price target decreased to €31.50Down from €36.00, the current price target is an average from 2 analysts. New target price is 53% above last closing price of €20.60. Stock is down 44% over the past year. The company is forecast to post earnings per share of €1.85 for next year compared to €1.85 last year.
공시 • Nov 08+ 4 more updatesNabaltec AG, Annual General Meeting, Jun 28, 2023Nabaltec AG, Annual General Meeting, Jun 28, 2023.
Price Target Changed • Oct 20Price target decreased to €31.50Down from €36.00, the current price target is an average from 2 analysts. New target price is 54% above last closing price of €20.50. Stock is down 36% over the past year. The company is forecast to post earnings per share of €2.03 for next year compared to €1.85 last year.
Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: €0.64 (vs €0.49 in 2Q 2021)Second quarter 2022 results: EPS: €0.64 (up from €0.49 in 2Q 2021). Revenue: €57.3m (up 19% from 2Q 2021). Net income: €5.60m (up 29% from 2Q 2021). Profit margin: 9.8% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 9.0%, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 6% per year.
Valuation Update With 7 Day Price Move • Jul 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to €26.90, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 8x in the Chemicals industry in Germany. Total loss to shareholders of 18% over the past three years.
Upcoming Dividend • Jun 23Upcoming dividend of €0.25 per shareEligible shareholders must have bought the stock before 30 June 2022. Payment date: 04 July 2022. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.7%).
Reported Earnings • Jun 04First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.53 (up from €0.27 in 1Q 2021). Revenue: €55.0m (up 19% from 1Q 2021). Net income: €4.67m (up 96% from 1Q 2021). Profit margin: 8.5% (up from 5.2% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 14%, compared to a 6.2% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Price Target Changed • May 24Price target decreased to €37.50Down from €41.00, the current price target is an average from 2 analysts. New target price is 37% above last closing price of €27.40. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.92 for next year compared to €1.85 last year.
Reported Earnings • Apr 30Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: €1.85 loss per share (up from €2.23 loss in FY 2020). Revenue: €190.2m (up 19% from FY 2020). Net income: €16.3m (up €35.9m from FY 2020). Profit margin: 8.5% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 13%, compared to a 11% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 27Third quarter 2021 earnings: EPS exceeds analyst expectationsThird quarter 2021 results: EPS: €0.49 (up from €0.15 in 3Q 2020). Revenue: €47.4m (up 28% from 3Q 2020). Net income: €4.30m (up 217% from 3Q 2020). Profit margin: 9.1% (up from 3.6% in 3Q 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) exceeded analyst estimates. Earnings per share (EPS) surpassed analyst estimates. Over the next year, revenue is forecast to grow 11%, compared to a 4.4% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 113 percentage points per year, which is a significant difference in performance.
Price Target Changed • Oct 29Price target increased to €40.50Up from €37.00, the current price target is an average from 3 analysts. New target price is 23% above last closing price of €33.00. Stock is up 66% over the past year. The company is forecast to post earnings per share of €1.50 next year compared to a net loss per share of €2.23 last year.
Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS €0.49 (vs €0.12 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €48.5m (up 33% from 2Q 2020). Net income: €4.35m (up €5.40m from 2Q 2020). Profit margin: 9.0% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 100 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 28First quarter 2021 earnings released: EPS €0.27 (vs €0.14 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €46.1m (up 1.3% from 1Q 2020). Net income: €2.38m (up 98% from 1Q 2020). Profit margin: 5.2% (up from 2.6% in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance.
Price Target Changed • May 15Price target increased to €37.00Up from €31.50, the current price target is an average from 2 analysts. New target price is 15% above last closing price of €32.20. Stock is up 56% over the past year.
Reported Earnings • May 02Full year 2020 earnings released: €2.23 loss per share (vs €1.22 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: €162.5m (down 9.6% from FY 2019). Net loss: €19.7m (down 284% from profit in FY 2019). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
Price Target Changed • Apr 30Price target increased to €33.50Up from €30.50, the current price target is an average from 2 analysts. New target price is 6.0% above last closing price of €31.60. Stock is up 41% over the past year.
Is New 90 Day High Low • Feb 27New 90-day high: €29.80The company is up 15% from its price of €25.90 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €28.95 per share.
Is New 90 Day High Low • Nov 11New 90-day high: €23.00The company is up 21% from its price of €19.00 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €62.62 per share.
Is New 90 Day High Low • Oct 11New 90-day high: €21.00The company is up 2.0% from its price of €20.60 on 13 July 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €60.09 per share.